{
    "2018-01-03": [
        [
            {
                "time": "2017-unknown",
                "original_text": "承担赔付责任沃森生物预计导致2017年亏损",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "赔付责任",
                        "2017年",
                        "亏损"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "unknown",
                "original_text": "转让标的未达最低承诺值沃森生物担赔付责任",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "转让标的",
                        "最低承诺值",
                        "赔付责任"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-unknown",
                "original_text": "创新药产业深度报告暨2018年投资策略：拥抱医药创新的新时代",
                "features": {
                    "keywords": [
                        "创新药",
                        "产业",
                        "2018年",
                        "投资策略",
                        "医药创新"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "创新药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "unknown",
                "original_text": "大安制药未完成业绩承诺沃森生物将承担赔付责任",
                "features": {
                    "keywords": [
                        "大安制药",
                        "业绩承诺",
                        "沃森生物",
                        "赔付责任"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "unknown",
                "original_text": "生物制品行业点评：生物制品批签发管理办法修订利于行业发展",
                "features": {
                    "keywords": [
                        "生物制品",
                        "批签发管理办法",
                        "修订",
                        "行业发展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "unknown",
                "original_text": "医药生物行业:积极关注一致性评价进展",
                "features": {
                    "keywords": [
                        "医药生物",
                        "一致性评价",
                        "进展"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "1月3日早间公告",
                "features": {
                    "keywords": [
                        "早间公告",
                        "1月3日"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "早间公告：沃森生物称转让标的血浆采集未达最低承诺值",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "转让标的",
                        "血浆采集",
                        "最低承诺值"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-03",
                "original_text": "沃森生物：转让标的大理制药血浆采集未达最低承诺值公司将承担相应赔付责任",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "大理制药",
                        "血浆采集",
                        "最低承诺值",
                        "赔付责任"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}